This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Dec;31(12):1617-9.

doi: 10.1016/j.leukres.2007.06.003. Epub 2007 Aug 10.

A new look at apoptosis in MDS; an uneasy neighbor

PMID: 17692912
DOI: 10.1016/j.leukres.2007.06.003

Review

A new look at apoptosis in MDS; an uneasy neighbor

Yataro Yoshida. Leuk Res. 2007 Dec.

. 2007 Dec;31(12):1617-9.

doi: 10.1016/j.leukres.2007.06.003. Epub 2007 Aug 10.

Author

PMID: 17692912
DOI: 10.1016/j.leukres.2007.06.003

No abstract available

PubMed Disclaimer

Comment on

Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactions.
Span LF, Rutten E, Gemmink A, Boezeman JB, Raymakers RA, de Witte T. Span LF, et al. Leuk Res. 2007 Dec;31(12):1659-67. doi: 10.1016/j.leukres.2007.06.013. Epub 2007 Jul 30. Leuk Res. 2007. PMID: 17659774

Similar articles

The role of apoptosis in myelodysplastic syndrome.
Invernizzi R. Invernizzi R. Haematologica. 2002 Apr;87(4):337-9. Haematologica. 2002. PMID: 11940474 No abstract available.
Are myelodysplastic syndromes and acute myeloid leukemia one disease?
Gale RP, Bennett JM. Gale RP, et al. Leuk Res. 2009 Mar;33(3):351-4. doi: 10.1016/j.leukres.2008.08.029. Epub 2008 Nov 8. Leuk Res. 2009. PMID: 18996594 Review. No abstract available.
Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes.
Schanz J, Jung H, Wörmann B, Gassmann W, Petersen T, Hinke A, Haase D. Schanz J, et al. Leuk Res. 2009 Sep;33(9):1183-8. doi: 10.1016/j.leukres.2009.03.027. Epub 2009 May 2. Leuk Res. 2009. PMID: 19411105 Clinical Trial.
Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes.
Satoh C, Tamura H, Yamashita T, Tsuji T, Dan K, Ogata K. Satoh C, et al. Leuk Res. 2009 Feb;33(2):326-31. doi: 10.1016/j.leukres.2008.07.006. Epub 2008 Aug 20. Leuk Res. 2009. PMID: 18718658
Transformation of myelodysplastic syndrome to T-cell acute lymphoblastic leukemia in a young adult.
Naithani R, Kumar R, Saxena R, Mahapatra M. Naithani R, et al. Pediatr Hematol Oncol. 2009 Mar;26(2):100-2. doi: 10.1080/08880010902754891. Pediatr Hematol Oncol. 2009. PMID: 19322741 Review. No abstract available.

See all similar articles

Cited by

Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis.
Zhao Y, Fei C, Zhang X, Zhang Y, Guo J, Gu S, Li X, Chang C. Zhao Y, et al. Tumour Biol. 2013 Feb;34(1):165-72. doi: 10.1007/s13277-012-0524-y. Epub 2012 Sep 28. Tumour Biol. 2013. PMID: 23055192

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal